Skip to Main Content

Author Details

Ming Shi
1997
418
67
PMIDPaper TitleJournal TitlePublished Year
37506543Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma.2023
37819944Lenvatinib, toripalimab plus FOLFOX chemotherapy in hepatocellular carcinoma patients with extrahepatic metastasis: A biomolecular exploratory, phase II trial (LTSC).2023
37579711Overexpression of CD99 is associated with tumor adaptiveness and indicates the tumor recurrence and therapeutic responses in gliomas.2023
37884999The Quartet Data Portal: integration of community-wide resources for multiomics quality control.Genome Biol2023
36968580assembly of a chromosome-level reference genome of the ornamental butterfly based on nanopore sequencing and Hi-C analysis.2023
36778023PAnno: A pharmacogenomics annotation tool for clinical genomic testing.2023
37082656NDRG2 regulates the formation of reactive astrocyte-derived progenitor cells Notch signaling pathway after brain traumatic injury in rats.2023
36931163Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries.2023
35051757Bisphenol F suppresses insulin-stimulated glucose metabolism in adipocytes by inhibiting IRS-1/PI3K/AKT pathway.Ecotoxicology and Environmental Safety2022
36310597Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report.Front Mol Biosci2022
36310160One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma.BMC Medicine2022
35844495Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma.Frontiers in Immunology2022
35768876Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples.Genome Biol2022
36097402Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma.Hepatology Communications2022
35387338Transcriptome Changes and Potential Immunotoxicity Analysis in RAW264.7 Macrophages Caused by Bisphenol F.Frontiers in Pharmacology2022
36153392A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers.Scientific data2022
35879681Gut microbiome changes in anti-N-methyl-D-aspartate receptor encephalitis patients.BMC Neurology2022
36270084Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer.Breast2022
35551205Comprehensive microRNA-seq transcriptomic profiling across 11 organs, 4 ages, and 2 sexes of Fischer 344 rats.Scientific data2022
35410795Corrigendum to "Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice" [Biochem. Biophys. Res. Commun. 603(2022) 29-34].Biochemical and Biophysical Research Communications2022
35981413Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial.European Journal of Cancer2022
35919459Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy.Molecular Therapy - Oncolytics2022
35782729BioVisReport: A Markdown-based lightweight website builder for reproducible and interactive visualization of results from peer-reviewed publications.Computational and Structural Biotechnology Journal2022
36529949Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials.2022
36455201Cell Infiltrative Inner Connected Porous Hydrogel Improves Neural Stem Cell Migration and Differentiation for Functional Repair of Spinal Cord Injury.ACS Biomaterials Science and Engineering2022
35316070Reply to J. Mei et al.Journal of Clinical Oncology2022
35276460Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice.Biochemical and Biophysical Research Communications2022
34980216Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.Genome Biol2022
34648352Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.Journal of Clinical Oncology2022
35342396Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma.Journal of Oncology2022
34930391Hidden biases in germline structural variant detection.Genome Biol2021
32049678Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection.European Journal of Gastroenterology and Hepatology2021
33907695Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.2021
33854567Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy lenvatinib alone for advanced hepatocellular carcinoma.Therapeutic Advances in Medical Oncology2021
33634987Forty-three key gene expressions involved in the effect of indoleamine 2,3-dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3-dioxygenase 1 inhibitor biomarker.Clinical and Translational Medicine2021
34166806Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score-Matching Analysis.Journal of Vascular and Interventional Radiology2021
34055599Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma.Frontiers in Oncology2021
34054530Investigation of the Multi-Target Mechanism of Guanxin-Shutong Capsule in Cerebrovascular Diseases: A Systems Pharmacology and Experimental Assessment.Frontiers in Pharmacology2021
33791252Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.2021
33519205Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin.Therapeutics and Clinical Risk Management2021
33933153Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient.Breast Cancer Research2021
34092242A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).Cancer Cell International2021
33718175Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma.Frontiers in Oncology2021
33557607Ginkgolide B promotes oligodendrocyte precursor cell differentiation and survival via Akt/CREB/bcl-2 signaling pathway after white matter lesion.Experimental Biology and Medicine2021
33863366A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.Genome Biol2021
33863344Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.Genome Biol2021
33813646Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.Cancer Immunology, Immunotherapy2021
34794449Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro.Cancer Cell International2021
34736145Cell-adaptable dynamic hydrogel reinforced with stem cells improves the functional repair of spinal cord injury by alleviating neuroinflammation.Biomaterials2021
34671549Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis.Front Oncol2021
  • 1 - 50 of 417

Recommended Authors

Collaborators

National Center for Toxicological Research
Co-authored papers 89
Co-authored papers 56
National Center for Toxicological Research (NCTR)
Co-authored papers 54
Co-authored papers 41
Co-authored papers 32
Co-authored papers 29
Co-authored papers 22
Co-authored papers 21
Co-authored papers 21
Co-authored papers 17
Co-authored papers 15
SAS Institute Inc Cary
Co-authored papers 13
SAS Institute
Co-authored papers 13
Department of Bioinformatics and Clinical Systems
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
Bio-X Institutes, Shanghai Jiao Tong University
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
College of Life Sciences, Zhejiang University
Co-authored papers 11
Co-authored papers 11
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
University Children's Hospital of Cologne
Co-authored papers 10
Co-authored papers 10
Co-authored papers 9
Feil Family Brain and Mind Research Institute.
Co-authored papers 9
Co-authored papers 9
Co-authored papers 8